Skopos Labs, Inc. Roivant Sciences Ltd. Transaction History
Skopos Labs, Inc.
- $330 Million
- Q4 2024
A detailed history of Skopos Labs, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Skopos Labs, Inc. holds 4 shares of ROIV stock, worth $45. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4Holding current value
$45% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
319Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$750 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$748 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$615 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$474 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$402 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.01B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...